Brainstorm Cell Therapeutics Inc. (BCLI): Capital Expenditures
Older than the company's other figures. The latest Capital Expenditures is for the year ended 2023-12-31, while the company's latest annual report covers the year ended 2025-12-31. Its later filings do not report this line under the concept TickerFacts maps.
$18.0K
Year ended 2023-12-31
-63.8%
3-year compound annual growth
-45.3%
5-year compound annual growth
-16.4%
10-year compound annual growth
| Period ended | Capital Expenditures | Change YoY | Source filing |
|---|---|---|---|
| 2023-12-31 | $18.0K | -37.9% | 2024-04-01, From 2023-01-01 |
| 2022-12-31 | $29.0K | -91.2% | 2024-04-01, From 2022-01-01 |
| 2021-12-31 | $330.0K | -12.7% | 2023-03-30, From 2021-01-01 |
| 2020-12-31 | $378.0K | -20.1% | 2022-03-28, From 2020-01-01 |
| 2019-12-31 | $473.0K | +28.2% | 2021-02-04, From 2019-01-01 |
| 2018-12-31 | $369.0K | +105.0% | 2020-02-18, From 2018-01-01 |
| 2017-12-31 | $180.0K | +74.8% | 2019-04-01, From 2017-01-01 |
| 2016-12-31 | $103.0K | +128.9% | 2018-03-08, From 2016-01-01 |
| 2015-12-31 | $45.0K | -72.0% | 2017-03-29, From 2015-01-01 |
| 2014-12-31 | $161.0K | +49.1% | 2016-03-09, From 2014-01-01 |
| 2013-12-31 | $108.0K | +20.0% | 2015-03-26, From 2013-01-01 |
| 2012-12-31 | $90.0K | +87.5% | 2014-03-27, From 2012-01-01 |
| 2011-12-31 | $48.0K | +860.0% | 2013-03-14, From 2011-01-01 |
| 2010-12-31 | $5.0K | n/a | 2012-03-15, From 2010-01-01 |